About
Antibody Drugs
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
450
By Phase
PHASE1: 2PHASE3: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
Today
Hover over trial bars to see details
Recent Trials
NCT01043016Lead Sponsor
Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors
PHASE1Unknown
18 participants
Started: Mar 31, 2009 · Completed: Apr 30, 2010
NCT00001027Collaborator
A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole
PHASE1Completed
32 participants
NCT00001028Collaborator
A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
PHASE3Completed
400 participants
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...